Long-term survival with eribulin monotherapy after whole brain radiation therapy in a patient with brain metastasis from breast cancer

Long-term survival with eribulin monotherapy after whole brain radiation therapy in a patient with brain metastasis from breast cancer

Bibliographic Details
Main Authors:	Sung Ui Jung, Chang Wan Jeon, Jin Hyuk Choi
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Asian Journal of Surgery
Subjects:	Breast cancer Brain metastasis Palliative chemotherapy Eribulin Whole brain radiation therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958420301317

Similar Items

The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
by: Irina V Kolyadina, et al.
Published: (2019-06-01)

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
by: Renaud Sabatier, et al.
Published: (2021-03-01)

Eribulin drug review
by: Nishitha Shetty, et al.
Published: (2014-01-01)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
by: Koliou P, et al.
Published: (2018-02-01)

Whole-Brain Radiation Therapy With Simultaneous Integrated Boost Versus Whole-Brain Radiation Therapy Plus Stereotactic Radiosurgery for the Treatment of Brain Metastasis From Lung Cancer
by: Binwei Lin, et al.
Published: (2021-03-01)

Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy
by: Wu S, et al.
Published: (2016-12-01)

Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
by: E V Artamonova
Published: (2017-09-01)

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
by: Vera A Gorbunova, et al.
Published: (2019-03-01)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
by: Binwei Lin, et al.
Published: (2020-04-01)

The neurocognitive function change criteria after whole-brain radiation therapy for brain metastasis, in reference to health-related quality of life changes: a prospective observation study
by: Toshimichi Nakano, et al.
Published: (2020-01-01)

Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases
by: Kunning Zhang, et al.
Published: (2023-12-01)

Efficacy of Eribulin in Soft Tissue Sarcomas
by: Edward Phillips, et al.
Published: (2022-03-01)

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis
by: Nayan Lamba, et al.
Published: (2017-06-01)

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
by: Han Sun, et al.
Published: (2018-12-01)

The Risk of Hippocampal Metastasis and the Associated High-Risk Factors in 411 Patients With Brain Metastases
by: Peng Xie, et al.
Published: (2022-02-01)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
by: Corinna Fritz, et al.
Published: (2018-11-01)

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
by: Meng Ni, et al.
Published: (2020-10-01)

Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
by: Minmin Li, et al.
Published: (2021-11-01)

Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies
by: Kristen Cagino, et al.
Published: (2020-11-01)

Brain metastasis in epithelial ovarian carcinoma: Case series
by: Shabnum Thakur, et al.
Published: (2020-01-01)

Eribulin and Confusion: A Previously Unknown Drug Side-Effect
by: Abu Baker Sheikh, et al.
Published: (2020-06-01)

Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival
by: Gabriella Frisk, et al.
Published: (2022-04-01)

The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
by: I V Kolyadina, et al.
Published: (2018-09-01)

Stereotactic radiosurgery versus whole-brain radiotherapy after resection of solitary brain metastasis: A systematic review and meta-analysis
by: Nikolaos Vlachos, et al.
Published: (2023-04-01)

Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
by: Eijiro Shimada, et al.
Published: (2021-10-01)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
by: R.F. Yang, et al.
Published: (2017-11-01)

Survival and effective prognostic factors in lung cancer patients with brain metastases treated with whole brain radiotherapy
by: Bixin Ren, et al.
Published: (2021-03-01)

Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12)
by: Jae Sik Kim, et al.
Published: (2021-12-01)

Transfer Learning Approach to Vascular Permeability Changes in Brain Metastasis Post-Whole-Brain Radiotherapy
by: Chad A. Arledge, et al.
Published: (2023-05-01)

Three cases of brain metastasis from castration‐resistant prostate cancer
by: Yohei Shida, et al.
Published: (2020-01-01)

Role of DOSE Escalation in whole Brain Radiotherapy for Brain Metastasis in Patients with a Favorable Survival Prognosis
by: Saroj Dhaka, et al.
Published: (2022-02-01)

Negative 18F-FET PET/CT in brain metastasis recurrence: a teaching case report
by: Samirah Alshehri, et al.
Published: (2021-11-01)

Answering the Big Clinical Questions in Brain Metastasis Management
by: John P. Kirkpatrick, et al.
Published: (2022-01-01)

Lymphocytopenia and survival after whole‐brain radiotherapy in patients with small‐cell lung cancer
by: Yu‐Jung Lin, et al.
Published: (2023-05-01)

Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment
by: Daniel Taussky, et al.
Published: (2012-03-01)

Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis
by: Rebecca Buecker, et al.
Published: (2019-03-01)

Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
by: Milana Bergamino Sirvén, et al.
Published: (2019-11-01)

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis
by: Yeshwanth R. Vedire, MD, et al.
Published: (2023-06-01)

Stathmin dynamics modulate the activity of eribulin in breast cancer cells
by: Mikihiro Yoshie, et al.
Published: (2021-08-01)

Brain metastasis in two patients with stage IA papillary serous carcinoma of the uterus
by: Deepa M. Narasimhulu, et al.
Published: (2015-08-01)